Eukaryotic Expression Systems Market Size by Host Type, Product Type, Application, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2029

5.46%
CAGR (2023-2029)
3.55 USD Mn.
Market Size
330
Report Pages
131
Market Tables

Overview

Eukaryotic Expression Systems Market size is expected to reach US$ 5.16 Mn. by year 2029 at a CAGR of 5.46% during the forecast period.

Eukaryotic Expression Systems Market Overview

Eukaryotic expression systems are the genetic constructs, which are frequently employed for the production of recombinant proteins or an RNA either inside or outside a cell. Expression systems are used in research and in the commercial production of enzymes or therapeutics.Eukaryotic Expression Systems Market

To Know About The Research Methodology :- Request Free Sample Report

Eukaryotic Expression Systems Market Dynamics

Rising patient pool for diseases like cardiovascular and cancer is anticipated to fuel the market growth.

The prevalence of these chronic diseases, especially in the geriatric population, rises the demand for developed therapeutics. Moreover, with high efficiency and minimum risk of side effects associated with protein therapeutics, technological advancements are expected to stimulate market growth. However, high cost, complexity, and time consumption may hamper the growth of the eukaryotic expression systems market during the forecast period.

The report has profiled key players in the market from different regions. However, the report has considered all market leaders, followers, and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed.

Eukaryotic Expression Systems Market Segment Analysis

The Eukaryotic Expression Systems market is segmented based on the Host type, Product type and Application.

Based on Host Type, the Baculovirus infected cells segment is expected to lead the market.Baculovirus vector systems are extensively used for the expression of foreign gene products in insect and mammalian cells.New advances increase the possibilities and applications of the Baculovirus expression system, which makes it possible to express multiple genes simultaneously within a single infected insect cell and to obtain multimeric proteins functionally similar to their natural analogs.

Based on Application, the therapeutics segment dominated the global market in 2022 and will continue the dominance throughout the forecast period. Rising incidences of chronic diseases and development in Research activities rises the demand for proteomics based research. These factors attribute to the segment growth.

Eukaryotic Expression Systems Market Regional Insights

North America is expected to dominate global market during forecast years.

Advancements in research facilities and increased funding for the same increased usage of protein technologies, and it therapeutic applications for the treatment of cancer and other genetic diseases, the rapid evolution of the pharmaceutical industry are the factors driving the market in North America.

Asia Pacific is expected to witness fastest growth.

The Asia Pacific will command the global market owing to the drivers like improved medical infrastructure, presence of large target population suffering from life threatening diseases like cancer, increased awareness, and development of innovative and cost-effective solutions, and rise in disposable income.
The report also helps in understanding Eukaryotic Expression Systems Market dynamics, structure by analyzing the market segments and project the Eukaryotic Expression Systems Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Eukaryotic Expression Systems Market make the report investor’s guide.

Eukaryotic Expression Systems Market Scope report: Inquire before buying

Eukaryotic Expression Systems Market
Report Coverage Details
Base Year: 2022 Forecast Period: 2023-2029
Historical Data: 2017 to 2022 Market Size in 2022: US $ 3.55 Mn.
Forecast Period 2023 to 2029 CAGR: 5.46% Market Size in 2029: US $ 5.16 Mn.
Segments Covered: by Host Type • S.cerevisiae
• Filamentous fungi
• Leishmania
• Baculovirus infected cells
by Product Type • Reagents
• Expression Vectors
• Competent Cells
by Application • Therapeutic Applications
• Industrial Applications
• Research Applications

Eukaryotic Expression Systems Market, by Region

• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)

Key players operating in Eukaryotic Expression Systems Market:

• Thermo Fisher Scientific
• Life Technologies Corporation
• Jena Biosciences
• New England Biolabs
• Takara Bio Inc.
• Bio-Rad Laboratories, Inc.
• Promega Corporation
• Agilent Technologies, Inc.
• Merck KGaA
• Sigma Aldrich Co.
• QIAGEN
• Lonza Group Ltd.
• GenScript Biotech Corporation

Frequently Asked Questions:

1. Which region has the largest share in Global Eukaryotic Expression Systems Market?
Ans: North America region held the highest share in 2022.

2. What is the growth rate of Global Eukaryotic Expression Systems Market?
Ans: The Global Eukaryotic Expression Systems Market is growing at a CAGR of 5.46% during forecasting period 2023-2029.

3. What is scope of the Global Eukaryotic Expression Systems Market report?
Ans: Global Eukaryotic Expression Systems Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Eukaryotic Expression Systems Market?
Ans: The important key players in the Global Eukaryotic Expression Systems Market are – Thermo Fisher Scientific,Life Technologies Corporation,Jena Biosciences,New England Biolabs,Takara Bio Inc.,Bio-Rad Laboratories, Inc.,Promega Corporation,Agilent Technologies, Inc.,Merck KGaA,Sigma Aldrich Co.,QIAGEN,Lonza Group Ltd.,GenScript Biotech Corporation

5. What is the study period of this Market?
Ans: The Global Eukaryotic Expression Systems Market is studied from 2022 to 2029.

Table of Contents

Global Eukaryotic Expression Systems Market

1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Eukaryotic Expression Systems Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2022 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Eukaryotic Expression Systems Market 3.4. Geographical Snapshot of the Eukaryotic Expression Systems Market, By Manufacturer share 4. Global Eukaryotic Expression Systems Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Eukaryotic Expression Systems Market 5. Supply Side and Demand Side Indicators 6. Global Eukaryotic Expression Systems Market Analysis and Forecast, 2022-2029 6.1. Global Eukaryotic Expression Systems Market Size & Y-o-Y Growth Analysis. 7. Global Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 7.1.1. S.cerevisiae 7.1.2. Filamentous fungi 7.1.3. Leishmania 7.1.4. Baculovirus infected cells 7.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 7.2.1. Reagents 7.2.2. Expression Vectors 7.2.3. Competent Cells 7.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 7.3.1. Therapeutic Applications 7.3.2. Industrial Applications 7.3.3. Research Applications 8. Global Eukaryotic Expression Systems Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 9.1.1. S.cerevisiae 9.1.2. Filamentous fungi 9.1.3. Leishmania 9.1.4. Baculovirus infected cells 9.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 9.2.1. Reagents 9.2.2. Expression Vectors 9.2.3. Competent Cells 9.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 9.3.1. Therapeutic Applications 9.3.2. Industrial Applications 9.3.3. Research Applications 10. North America Eukaryotic Expression Systems Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 11.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 12. Canada Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 12.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 13. Mexico Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 13.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 14. Europe Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 14.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 15. Europe Eukaryotic Expression Systems Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 16.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 17. France Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 17.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 18. Germany Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 18.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 19. Italy Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 19.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 20. Spain Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 20.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 21. Sweden Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 21.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 22. CIS Countries Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 22.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 23. Rest of Europe Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 23.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 23.4. Market Size (Value) Estimates & Forecast By End users, 2022-2029 24. Asia Pacific Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 24.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 25. Asia Pacific Eukaryotic Expression Systems Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 26.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 27. India Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 27.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 28. Japan Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 28.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 29. South Korea Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 29.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 30. Australia Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 30.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 31. ASEAN Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 31.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 32. Rest of Asia Pacific Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 32.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 33. Middle East Africa Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 33.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 34. Middle East Africa Eukaryotic Expression Systems Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 35.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 36. GCC Countries Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 36.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 37. Egypt Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 37.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 38. Nigeria Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 38.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 39. Rest of ME&A Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 39.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 40. South America Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 40.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 41. South America Eukaryotic Expression Systems Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 42.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 43. Argentina Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 43.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 44. Rest of South America Eukaryotic Expression Systems Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Host Type, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By Product Type, 2022-2029 44.3. Market Size (Value) Estimates & Forecast By Application, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Eukaryotic Expression Systems Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Applications 45.2.3.2. M&A Key Players, Forward Integration and Backward Integration 45.3. Company Profile - Thermo Fisher Scientific 45.3.1. Company Overview 45.3.2. Financial Overview 45.3.3. Geographic Footprint 45.3.4. Product Portfolio 45.3.5. Business Strategy 45.3.6. Recent Developments 45.4. Life Technologies Corporation 45.5. Jena Biosciences 45.6. New England Biolabs 45.7. Takara Bio Inc. 45.8. Bio-Rad Laboratories, Inc. 45.9. Promega Corporation 45.10. Agilent Technologies, Inc. 45.11. Merck KGaA 45.12. Sigma Aldrich Co. 45.13. QIAGEN 45.14. Lonza Group Ltd. 45.15. GenScript Biotech Corporation 46. Primary Key Insights